CTSD and Alzheimer disease: Our data indicate that disomic individuals who have EOAD have decreased cathepsin D activity, this suggests that decreased enzyme activity may be attributable to the early development of AD in mid-life rather than a direct effect of three copies of Hsa21 and these processes may differ in EOAD and LOAD.